Connor, Clark & Lunn Investment Management (CC&L)’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-358	Closed	-$8K	–	1290
2021 Q4	$8K	Sell	358 -14,066	-98%	-$376K	﹤0.01%	1059
2021 Q3	$472K	Sell	14,424 -1,946	-12%	-$71.3K	﹤0.01%	782
2021 Q2	$683K	Buy	16,370 +8,270	+102%	+$424K	﹤0.01%	728
2021 Q1	$530K	Buy	+8,100	New	+$565K	﹤0.01%	788
2020 Q2	–	Sell	-459	Closed	-$24K	–	1225
2020 Q1	$24K	Buy	+459	New	+$48K	﹤0.01%	984
2019 Q3	–	Sell	-854	Closed	-$109K	–	1128
2019 Q2	$109K	Buy	854 +327	+62%	+$47.1K	﹤0.01%	944
2019 Q1	$95K	Sell	527 -15	-3%	-$2.17K	﹤0.01%	869
2018 Q4	$60K	Sell	542 -94	-15%	-$12.2K	﹤0.01%	922
2018 Q3	$86K	Buy	+636	New	+$87.7K	﹤0.01%	890
2013 Q4	–	Sell	-533	Closed	-$62K	–	774
2013 Q3	$62K	Buy	+533	New	+$60.5K	﹤0.01%	498

Other funds holding SRGA

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CLG

Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AWS

Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s SRGA Position: Q1 2022 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q1 2022, closing a stake of 358 shares — an estimated $8K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in SRGA in Q3 2013 and held it in 10 quarters. The position peaked at $683K in Q2 2021. 77 funds tracked by Wall St. Rank hold SRGA as of Q1 2022.

Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Connor, Clark & Lunn Investment Management (CC&L) sold 358 Surgalign Holdings, Inc. Common Stock shares in Q1 2022, an estimated $8K.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Surgalign Holdings, Inc. Common Stock in Q3 2013 and held it in 10 quarters.
Connor, Clark & Lunn Investment Management (CC&L)'s Surgalign Holdings, Inc. Common Stock position peaked at $683K in Q2 2021.
77 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q1 2022.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2022, filed 12 May 2022.